Hearn AP - Search Results

1

Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapy.

Hearn AP, Hug OD, Somani ZA, Kavanagh J, d'Ancona G, Roxas C, Green L, Thomson L, Fernandes M, Kent BD, Dhariwal J, Nanzer AM, Jackson DJ. Hearn AP, et al. Eur Respir J. 2021 Jun 10;57(6):2100166. doi: 10.1183/13993003.00166-2021. Print 2021 Jun. Eur Respir J. 2021. PMID: 33632798 Free article. No abstract available.

2

Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma.

Kavanagh JE, Hearn AP, Dhariwal J, d'Ancona G, Douiri A, Roxas C, Fernandes M, Green L, Thomson L, Nanzer AM, Kent BD, Jackson DJ. Kavanagh JE, et al. Among authors: hearn ap. Chest. 2021 Feb;159(2):496-506. doi: 10.1016/j.chest.2020.08.2083. Epub 2020 Aug 31. Chest. 2021. PMID: 32882249

3

Biologic treatment options for severe asthma.

Hearn AP, Kent BD, Jackson DJ. Hearn AP, et al. Curr Opin Immunol. 2020 Oct;66:151-160. doi: 10.1016/j.coi.2020.10.004. Epub 2020 Nov 16. Curr Opin Immunol. 2020. PMID: 33212388 Review.

4

Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis.

Nanzer AM, Dhariwal J, Kavanagh J, Hearn A, Fernandes M, Thomson L, Roxas C, Green L, D'Ancona G, Agarwal S, Kent BD, Jackson DJ. Nanzer AM, et al. ERJ Open Res. 2020 Nov 10;6(4):00451-2020. doi: 10.1183/23120541.00451-2020. eCollection 2020 Oct. ERJ Open Res. 2020. PMID: 33263051 Free PMC article.

5

Benralizumab after sub-optimal response to mepolizumab in severe eosinophilic asthma.

Kavanagh JE, Hearn AP, d'Ancona G, Dhariwal J, Roxas C, Green L, Thomson L, Fernandes M, Kent BD, Nanzer AM, Jackson DJ. Kavanagh JE, et al. Among authors: hearn ap. Allergy. 2021 Jun;76(6):1890-1893. doi: 10.1111/all.14693. Epub 2020 Dec 23. Allergy. 2021. PMID: 33300186 No abstract available.

6

Adherence to inhaled corticosteroids and clinical outcomes following a year of benralizumab therapy for severe eosinophilic asthma.

d'Ancona G, Kavanagh JE, Dhariwal J, Hearn AP, Roxas C, Fernandes M, Green L, Thomson L, Nanzer AM, Jackson DJ, Kent BD. d'Ancona G, et al. Among authors: hearn ap. Allergy. 2021 Jul;76(7):2238-2241. doi: 10.1111/all.14737. Epub 2021 Jan 26. Allergy. 2021. PMID: 33432682 No abstract available.

7

The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma.

Hearn AP, Kavanagh J, d'Ancona G, Roxas C, Green L, Thomson L, Fernandes M, Kent BD, Dhariwal J, Nanzer AM, Jackson DJ. Hearn AP, et al. J Allergy Clin Immunol Pract. 2021 May;9(5):2093-2096.e1. doi: 10.1016/j.jaip.2021.01.008. Epub 2021 Jan 21. J Allergy Clin Immunol Pract. 2021. PMID: 33486140 No abstract available.

8

The impact of the first COVID-19 surge on severe asthma patients in the UK. Which is worse: the virus or the lockdown?

Smith SJ, Busby J, Heaney LG, Pfeffer PE, Jackson DJ, Yang F, Fowler SJ, Menzies-Gow A, Idris E, Brown T, Gore R, Faruqi S, Dennison P, Dodd JW, Doe S, Mansur AH, Priyadarshi R, Holmes J, Hearn A, Al-Aqqad H, Loewenthal L, Cooper A, Fox L, Selvan M, Crooks MG, Thompson A, Higbee D, Fawdon M, Nathwani V, Holmes L, Chaudhuri R. Smith SJ, et al. ERJ Open Res. 2021 Feb 1;7(1):00768-2020. doi: 10.1183/23120541.00768-2020. eCollection 2021 Jan. ERJ Open Res. 2021. PMID: 33564672 Free PMC article.

9

Real-World Effectiveness of Anti-IL-5/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal Sensitization.

Dhariwal J, Hearn AP, Kavanagh JE, d'Ancona G, Green L, Fernandes M, Thomson L, Roxas C, Kent BD, Nanzer AM, Jackson DJ. Dhariwal J, et al. Among authors: hearn ap. J Allergy Clin Immunol Pract. 2021 Jun;9(6):2315-2320.e1. doi: 10.1016/j.jaip.2021.02.048. Epub 2021 Mar 6. J Allergy Clin Immunol Pract. 2021. PMID: 33689868

10

The prevalence of mucus plugging in severe eosinophilic asthma and its relationship to clinical efficacy of anti-IL-5R treatment.

Hearn AP, Mak MS, Budaj I, Qurashi N, Snell O, Dhariwal J, Nanzer AM, Jackson DJ. Hearn AP, et al. J Allergy Clin Immunol Pract. 2022 Apr;10(4):1102-1103.e1. doi: 10.1016/j.jaip.2021.12.024. Epub 2022 Jan 1. J Allergy Clin Immunol Pract. 2022. PMID: 34979335 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters